GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Ligand Pharmaceuticals Incorporated (LGND) [hlAlert]

Rating:
Hold LGND
up 19.96 %

Ligand Pharmaceuticals Incorporated (LGND) downgraded to Hold with price target $94 by Deutsche Bank

Posted on: Monday,  Jun 15, 2015  12:25 PM ET by Deutsche Bank

Deutsche Bank rated Hold Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on 06/15/2015. Previously Deutsche Bank rated Buy Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on
04/01/2015., when the stock price was $76.55. Since then, Ligand Pharmaceuticals Incorporated has gained 19.96% as of 06/15/2015's recent price of $91.83.
If you would have followed the previous Deutsche Bank's recommendation on LGND, you would have gained 19.96% of your investment in 75 days.

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/15/2015 12:25 PM Hold
None
91.83 94.00
as of 8/27/2015
1 Week   
1 Month   
3 Months up  9.16 %
1 YTD up  19.96 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/1/2015 2:25 PM Buy
None
76.55 94.00
12/2/2014 1:25 PM Buy
None
55.30 74.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy